These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 15669126)

  • 1. Reyataz may cause EKG abnormality.
    AIDS Patient Care STDS; 2004 Dec; 18(12):737. PubMed ID: 15669126
    [No Abstract]   [Full Text] [Related]  

  • 2. Boosted Reyataz comparable to Kaletra.
    AIDS Patient Care STDS; 2005 Jan; 19(1):60. PubMed ID: 15700399
    [No Abstract]   [Full Text] [Related]  

  • 3. Revised package insert for atazanavir.
    Sax PE
    AIDS Clin Care; 2008 Mar; 20(3):23. PubMed ID: 18399014
    [No Abstract]   [Full Text] [Related]  

  • 4. Labeling changes for Reyataz.
    AIDS Patient Care STDS; 2008 Sep; 22(9):761. PubMed ID: 18802976
    [No Abstract]   [Full Text] [Related]  

  • 5. Ritonavir-boosted atazanavir, methadone, and ventricular tachycardia: 2 case reports.
    Gallagher DP; Kieran J; Sheehan G; Lambert J; Mahon N; Mallon PW
    Clin Infect Dis; 2008 Aug; 47(3):e36-8. PubMed ID: 18558878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electrocardiographic changes in HIV-infected, drug-experienced patients being treated with atazanavir.
    Gianotti N; Guffanti M; Galli L; Margonato A; Chiaravalli G; Bigoloni A; Lazzarin A; Castagna A
    AIDS; 2007 Jul; 21(12):1648-51. PubMed ID: 17630564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FDA notifications. Updates made to Reyataz package insert.
    AIDS Alert; 2008 Oct; 23(10):116-7. PubMed ID: 18935687
    [No Abstract]   [Full Text] [Related]  

  • 8. Skin rash associated with atazanavir: report of three cases.
    Ouagari Z; Tubiana R; Mohand HA; Dominguez S; Duvivier C; Bricaire F; Katlama C; Caumes E
    AIDS; 2006 May; 20(8):1207-8. PubMed ID: 16691076
    [No Abstract]   [Full Text] [Related]  

  • 9. Rash in an HIV-positive patient.
    Herzmann C; Kinloch S; Johnson M
    HIV Med; 2005 Nov; 6(6):379. PubMed ID: 16268818
    [No Abstract]   [Full Text] [Related]  

  • 10. Alopecia associated with ritonavir-boosted atazanavir therapy.
    Torres HA; Barnett BJ; Arduino RC
    AIDS; 2007 Jun; 21(10):1391-2. PubMed ID: 17545728
    [No Abstract]   [Full Text] [Related]  

  • 11. Prolonged QT interval and torsades de pointes associated with atazanavir therapy.
    Ly T; Ruiz ME
    Clin Infect Dis; 2007 Mar; 44(6):e67-8. PubMed ID: 17304444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated alkaline phosphatase with raltegravir in a treatment experienced HIV patient.
    Fleischbein E; O'Brien J; Martelino R; Fenstersheib M
    AIDS; 2008 Nov; 22(17):2404-5. PubMed ID: 18981785
    [No Abstract]   [Full Text] [Related]  

  • 13. Atazanavir-associated menorrhagia.
    Paparizos VA; Kourkounti S; Leuow K; Kyriakis KP; Botsi C; Katsambas AD
    Int J STD AIDS; 2007 Sep; 18(9):651-2. PubMed ID: 17785018
    [No Abstract]   [Full Text] [Related]  

  • 14. Atazanavir-containing renal calculi in an HIV-infected patient.
    Anderson PL; Lichtenstein KA; Gerig NE; Kiser JJ; Bushman LR
    AIDS; 2007 May; 21(8):1060-2. PubMed ID: 17457108
    [No Abstract]   [Full Text] [Related]  

  • 15. Atazanavir urinary stones in an HIV-infected patient.
    Pacanowski J; Poirier JM; Petit I; Meynard JL; Girard PM
    AIDS; 2006 Oct; 20(16):2131. PubMed ID: 17053366
    [No Abstract]   [Full Text] [Related]  

  • 16. Drug interactions. Kaletra and atazanavir.
    TreatmentUpdate; 2006; 18(3):7-8. PubMed ID: 17211919
    [No Abstract]   [Full Text] [Related]  

  • 17. A comparison of different protease inhibitors on coronary heart disease risk.
    Coleman CI; White CM
    Conn Med; 2007 Jan; 71(1):15-7. PubMed ID: 17288101
    [No Abstract]   [Full Text] [Related]  

  • 18. [New data on atazanavir/r]].
    MMW Fortschr Med; 2005 Apr; 147 Spec No 1():81-3. PubMed ID: 16385887
    [No Abstract]   [Full Text] [Related]  

  • 19. Anti-HIV agents. Kaletra + atazanavir.
    TreatmentUpdate; 2005; 17(5):5. PubMed ID: 17219657
    [No Abstract]   [Full Text] [Related]  

  • 20. Can boosted atazanavir induce hyperlipotrophy?
    Dellamonica P
    J Infect; 2006 Jun; 52(6):e189-90. PubMed ID: 16239035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.